|
MEX3A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.25900000319734E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.64620000023363E-07 |
| Normal-vs-Stage2 |
1.541550E-02 |
| Normal-vs-Stage3 |
9.458100E-02 |
| Normal-vs-Stage4 |
9.401700E-02 |
| Stage1-vs-Stage2 |
6.422600E-01 |
| Stage1-vs-Stage3 |
1.347570E-01 |
| Stage1-vs-Stage4 |
5.233000E-01 |
| Stage2-vs-Stage3 |
4.966200E-01 |
| Stage2-vs-Stage4 |
7.932800E-01 |
| Stage3-vs-Stage4 |
7.594600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.88159998271954E-09 |
| Normal-vs-AfricanAmerican |
2.898200E-03 |
| Normal-vs-Asian |
5.228200E-01 |
| Caucasian-vs-AfricanAmerican |
4.638300E-03 |
| Caucasian-vs-Asian |
2.395000E-01 |
| AfricanAmerican-vs-Asian |
3.667000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.27870000038644E-08 |
| Normal-vs-Female |
3.562700E-04 |
| Male-vs-Female |
6.124400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.443610E-03 |
| Normal-vs-Extreme_Weight |
1.83552999999392E-05 |
| Normal-vs-Obese |
3.60879999999897E-05 |
| Normal-vs-Extreme_Obese |
3.304200E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.838800E-01 |
| Normal_Weight-vs-Obese |
1.359640E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.309000E-01 |
| Extreme_Weight-vs-Obese |
2.289600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.457200E-01 |
| Obese-vs-Extreme_Obese |
9.700200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.422100E-03 |
| Normal-vs-Age(41-60Yrs) |
2.33520000003651E-08 |
| Normal-vs-Age(61-80Yrs) |
3.53330000002483E-06 |
| Normal-vs-Age(81-100Yrs) |
8.113800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.931000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.581200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.764000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.234800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.212700E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.938210E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.42630351973594E-11 |
| Normal-VS-Type2 PRCC |
4.003400E-01 |
| Normal-VS-KIRP CIMP |
9.497400E-01 |
| Normal-VS-Unclassified PRCC |
2.383900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.6232128408642E-12 |
| Type1 PRCC-VS-KIRP CIMP |
2.15719999996367E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
2.232000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.361000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.620600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.522100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.924800E-03 |
| Normal-vs-N1 |
3.467500E-02 |
| Normal-vs-N2 |
2.216800E-01 |
| N0-vs-N1 |
4.082600E-01 |
| N0-vs-N2 |
2.050800E-01 |
| N1-vs-N2 |
7.134600E-01 |
|
|
